4 - Avalo Therapeutics, Inc. (0001534120) (Issuer) | Filings Insight

Avalo Therapeutics, Inc.

0001534120 Nasdaq

4 - Avalo Therapeutics, Inc. (0001534120) (Issuer)[0]

[4]Statement of changes in beneficial ownership of securities(접수일: 2025-04-01[적용일2025-03-28])

[REPORTING-OWNER]Sullivan Christopher Ryan | [ISSUER]Avalo Therapeutics, Inc. |

/ 0

4 - Avalo Therapeutics, Inc. (0001534120) (Issuer) | Filings Insight